Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. - Al-Onazi AS; Al-Rasheed NM; Attia HA; Ahmed RM; Al-Amin MA; Poizat C (The Journal of pharmacy and pharmacology, 2016)